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Abstract 
In this paper, a feature-based bio-CAD modeling of three-dimensional tissue scaffolds by considering spatial distribution of biologically active 
materials is presented for biomanufacturing and tissue engineering applications. Proposed model is based on uniform distribution of bio-active 
particles in different regions of scaffold, which is constrained by geometrical and biological features. The proposed method was integrated with 
a recently developed method of multi-material additive manufacturing of hydrogel structures, for bio-additive manufacturing of the heterogeneous 
scaffolds.  3D bioprinted heterogeneous scaffolds were provided as an example for physical implementation of developed algorithm to validate 
the model. 
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1. Introduction 
Tissue engineering is a complex process where a porous 
scaffold with or without cells is used to heal or regenerate the 
targeted tissue. The sequence of events is guided by a series of 
growth factors, cytokines, cell-cell and cell-matrix interactions. 
To imitate nature’s healing environment, these scaffolds must 
incorporate vital growth factors or proteins that are able to act 
on cell migration, differentiation, proliferation and organization 
in a functional tissue. These growth factors are polypeptides 
that transmit signals to modulate cellular activities. Thus, 
proliferation and other behaviors of cells on advanced bio-
specific materials can be controlled by incorporating a 
controlled release of bioactive particles, such as natural growth 
factors, hormones, enzymes or synthetic cell cycle regulators 
[1]. These bioactive particles will deliver the appropriate, 
necessary cues in a controlled spatial and temporal fashion to 
improve healing or tissue regeneration. However, a major 
challenge lies in developing efficient delivery mechanisms to 
mimic the in vivo release profiles of growth factors produced 
during natural tissue morphogenesis or repair [2]. 
In the literature, several heterogeneous object modeling 
techniques have been proposed for solid modeling of consumer 
products: the rm-object approach is used for representing 
heterogeneous objects by Kumar and Dutta [3]. This method 
represents the material variation as functions of spatial position 
relative to a reference entity and material variations were 
assumed to be given a priori. Samanta and Koc [4] have 
proposed feature based heterogeneous object modeling using 
B-spline surfaces and B-spline volumes to represent 2D and 
3D-dependent material distributions using the same set of 
control points for both the geometries and the material 
compositions. Weiss et al [5] have presented a Bayesian 
methodology for computer-aided experimental design of 
heterogeneous fibrin-based scaffolds having spatial distribution 
of growth factors designed to induce and direct the growth of 
new tissue as the scaffold degrades. 
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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However, these heterogeneous object modeling techniques 
assume a continuous variation of materials throughout the 
designed object, whereas in tissue scaffolds bioactive particles 
are discrete entities and need to be spatially distributed in a 
controlled manner within the porous scaffold. Af  
 
 
 
Fig. 1. Overall procedure of modeling and design of biomimetic tissue scaffold 
 
 
Fig. 2. Feature based heterogeneous scaffold model hierarchy 
Hence, the existing heterogeneous object modeling techniques 
cannot be directly used in modeling of tissue scaffolds with 
controlled distribution of bioactive particles. 
During the past decade, extensive studies on multi-material 
additive manufacturing by using multi-nozzle deposition 
systems were resulted in numerous reports on fabrication of 
heterogeneous scaffolds addressed to be used in biomedical 
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applications [6-8]. However, there are still concerns about the 
precision of spatial distribution of multi-material segments in 
fabricated object, especially in controlling the structural 
integrity of printed constructs. Single nozzle deposition systems 
were developed to provide a solution [9-11], but they have been 
often resulted in formation of the transient sections and lack of 
control in continuity of functionality of neighboring regions, 
due to the mixing of consequent materials during deposition. 
This problem becomes more evident when these designs were 
intended to be used in deposition of considerably small regions 
of materials with altering features. We developed a method [12] 
to fabricate heterogeneous 3D structures with precise control 
the functionality of multi-material segments while the structural 
integrity and continuity could be preserved during the printing. 
In this paper, this method was used to implement the developed 
algorithm to ensure that the design criteria were implemented 
in a controllable manner. 
In order to better mimic aspects of nature or to enable 
biologically inspired engineered designs, new scaffold design 
and fabrication methods must include heterogeneous 
compositions incorporating controlled spatial distributions of 
cells, growth factors, and proteins. In this paper, a novel bio-
mimetic model that uses feature based design technique for 
complex and irregular growth factor heterogeneities in 
scaffolds is proposed. This new design technique will allow 
simultaneous deposition of biomaterials and bioactive particles 
along with biomimetic placements of cells and proteins within 
3D scaffold structures. Using the shape of tissue regeneration 
area, heterogeneous scaffold that will mimic the release profiles 
of growth factors produced during natural tissue morphogenesis 
or tissue repair are modelled. This paper is organized as 
follows: the feature-based biomimetic modelling of scaffolds is 
discussed in section 2. Biomimetic design of scaffolds with 
growth factors is explained in Section 3. Implementation of 
developed algorithm is presented in section 4.  
2. spatially controlled growth factor distribution  
The overall procedure for feature based biomimetic 
modeling of heterogeneous scaffolds is shown in Fig. 1. A 
wound model which is used through this presentation is shown 
in Fig. 1(a). Three-dimensional model is constructed using 
proper image processing methods Fig. 1(b) and segmentation. 
After obtaining the 3D model of healing area, biological 
features that will govern the spatial distribution of growth 
factors are identified. Further, the heterogeneous scaffold is 
modeled with biologically active particle distribution across 
each layer of scaffold as seen in Fig. 1(c). 
In this research, a feature-based representation model of 
heterogeneous scaffold with spatially controlled bioactive 
particle distribution is presented. The heterogeneous scaffold 
model hierarchy is shown in Fig. 2. A feature based 
representation scheme is used to represent heterogeneous 
scaffold with bioactive particles distributed between biological 
features. The heterogeneous scaffold ۶܁  composed of ܭ 
biological materials  ܤܯଵǡ ܤܯଶǡڮ ǡ ܤܯ௄  is modeled as 
follows: 
 
۶܁ ൌ ሺ܁۵ǡ ܂܀ǡ ۰ۻǡ ۰۱ሻ 
܁۵ ൌ ൛ሼܵܤ௠ሽǡ ሼܤܨ௟ሽൟǡ݉ ൌ ͳǡڮ ǡܯǢ ݈ ൌ ͳǡڮ ǡ ܮ܁۵ א ܧଷ 
܂܀ ൌ ൛ܴܶ௟భǡ௟మൟǡ ݈ଵ ൌ ͳǡڮ ǡ ܮǢ ݈ଶ ൌ ͳǡڮ ǡ ܮǢ ݈ଵ ് ݈ଶ 
۰ۻ ൌ ሼܤܯ௞ǡ ௞݂ሺ݃ሻሽǡ݇ ൌ Ͳǡڮ ǡ ܭ۰ۻ א ܸ௄ାଵ            (1) 
۰۱ ൌ ሼܤܥ௡ሽǡ݊ ൌ ͳǡڮ ǡܰ 
 
where, ܧଷ  is the three-dimensional Euclidean space and 
ܸ௄ାଵ is the ሺܭ ൅ ͳሻ-dimensional biological material space. In 
order to facilitate the design of heterogeneous scaffold 
consisting of varying bioactive particle distribution, biological 
entities are used as biological features. By selecting proper 
biological entities as the reference features and specifying a 
bioactive particle distribution function across the features, the 
distribution information can be incorporated with biological 
feature information. The biological feature can be an arbitrary 
feature of the tissue regeneration volume in the geometric form 
of a point, curve, surface or the entire boundary of the 
biological object [13]. In this way, the natural tissue 
regeneration process between the two wound features can be 
imitated. These features are represented by set ሼܤܨ௟ሽ termed as 
collection of ܮ  biological features ܤܨଵǡ ܤܨଶǡڮ ǡ ܤܨ௅ . The 
biological features are the specific shapes of the tissue 
regeneration area and contribute to the formation of the 
boundary of final scaffold geometry. 
scaffolds must be represented in 3D space. After wound 
volume are obtained using image processing techniques, the 
scaffold geometry ܁۵  is represented as set of scaffold 
boundaries ሼܵܤ௠ሽǡ ݉ ൌ 1ǡڮ ǡܯ  and set of biological 
features ሼܤܨ௟ሽǡ ݈ ൌ 1ǡ ڮ ǡ ܮ . Each of the scaffold 
boundaries ܵܤ௠  are modeled as NURBS surfaces of two 
parameters ݑ  and ݒ  mapped into Euclidean space ܧଷ . A 
NURBS surface ܵܤ௠ can be expressed as: 
 
ܵܤ௠ሺݑǡ ݒሻ ൌ
σ σ ௜ܰǡ௣ሺݑሻ ௝ܰǡ௤ሺݒሻ௜ǡ௝௜ǡ௝௃௝ୀ଴ூ௜ୀ଴
σ σ ௜ܰǡ௣ሺݑሻ ௝ܰǡ௤ሺݒሻ௜ǡ௝௃௝ୀ଴ூ௜ୀ଴
 (2) 
 
where, P௜ǡ௝ ൌ ቀx௜ǡ௝ǡ y௜ǡ௝ǡ z௜ǡ௝ቁ  and  w௜ǡ௝  are weights of each 
P௜ǡ௝. ௜ܰǡ௣ሺݑሻ, ௝ܰǡ௤ሺݒሻ are the B-spline basis functions defined 
on the knot vectors, ܷ and ܸ, with degree ݌ and ݍ respectively. 
The biological features are part of scaffold geometry and 
scaffold boundaries. Therefore, relation of biological 
featureܤܨ௟ with other biological features is maintained in the 
tissue relation set ܂܀ ൌ ൛ܴܶ௟భǡ௟మൟǡ ݈ଵ ൌ 1ǡڮ ǡ ܮǢ݈ଶ ൌ
1ǡ ڮ ǡ ܮǢ݈ଵ ് ݈ଶ.   
The ܭ ൅ ͳ biological materials are elements of biological 
material set ۰ۻ  defined in heterogeneous scaffold. For 
biomimetic design, it is assumed that the tissue regeneration 
starts from one biological feature and closes towards another 
biological feature. So, the bioactive particles required for tissue 
regeneration are assumed to vary in only one direction ሺ݃ሻ i.e. 
from one biological feature to another biological feature. This 
distribution of growth factors or proteins in micro-particles 
from one biological growth factors to another is represented by 
one-dimensional parametric function  ௞݂ሺ݃ሻ , where ݇ ൌ
Ͳǡڮ ǡ ܭ. Each element of ۰ۻ contains the biological material 
type ܤܯ௞  and their one dimensional mathematical form of 
variation  ௞݂ሺ݃ሻ , where ݇ ൌ Ͳǡڮ ǡ ܭ . Hence, ۰ۻ  belongs to 
ሺܭ ൅ ͳሻ-dimensional biological material space. Further, the 
biological material ܤܯ଴  is considered as the biodegradable 
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scaffold material and the biological material type ܤܯ௞ǡ ݇ ൌ
ͳǡڮ ǡ ܭ are considered as bioactive particles (growth factors or 
proteins). In tissue engineering, the bioactive micro-particle 
release rate should be varied as per desired distribution in order 
to bio-mimic healing process. So the biological material 
distribution functions ௞݂ሺ݃ሻ are constrained with at least one 
biological featureܤܨ௟ and are given by set۰۱ ൌ ሼܤܥ௡ሽǡ ݊ ൌ
ͳǡڮ ǡܰ. In other words, these biological material distribution 
functions constraints by tissue regeneration directions. In Fig. 
3, bioactive particles ܤܯ௞are distributed along one direction 
between biological featuresܤܨଵǡ ܤܨଶ. The bioactive particles 
ܤܯ௞  are distributed as given by function  ௞݂ሺ݃ሻ . Similarly, 
different types of growth factorsܤܯ௞, each having different 
distribution function  ௞݂ሺ݃ሻ  could be constrained between 
biological featuresܤܨ࢒  and the biological constraint is given 
byܤܥ௡. Fig. 4 shows one dimensional distribution of bioactive 
particles between different biological features. 
 
 
Fig. 3. Different regions and growth factor distribution in a layer. 
 
For bioprinting of the designed scaffold, the heterogeneous 
scaffold is modeled as set of layers. So, feature level 
representation is decomposed into layer level representation 
that uses the scaffold geometry information and biological 
material information at each layer. The set of layers is given 
by ۺ ൌ ሼۺܐሽǡ ݄ ൌ ͳǡڮ ǡܪ . Each layer ۺܐ  at 
height ݖ௛ represents scaffold geometric information and 
biomaterial information decomposed from feature level into 
discrete layers as per design requirements. Eachۺܐ satisfies 
the relation: 
 
ۺ૚ תۺ૛ ڮת ۺ۶ ൌ ׎                          (3) 
 
The height ݖ௛is determined using the porosity level ௛ܲǡ௛ାଵǡ
݄ ൌ ͳǡڮ ǡܪ  between any two layers required in 
heterogeneous scaffold.  A layer ۺܐ  can be represented as 
follows: 
ۺܐ ൌ ሺ܁ۺǡ ۵۱ǡ ܀۰ۻǡ۲۱ǡ ۺ۱ሻ 
܁ۺ ൌ ൛ሼܤܨ௟ሽǡ ሼܴ௥ሽǡ ൟǡ݈ ൌ ͳǡڮ ǡ ܮǢ ݎ ൌ ͳǡڮ ǡ ܴ 
۵۱ ൌ ൛ܩܥ௟ǡ௥ൟǡ ݈ ൌ ͳǡڮ ǡ ܮǢ ݎ ൌ ͳǡڮ ǡ ܴ 
܀۰ۻ ൌ ൛ܤܯ௞
ோೝൟǡ݇ ൌ ͳǡڮ ǡ ܭǢ ݎ ൌ ͳǡڮ ǡ ܴ 
۲۱ ൌ ሼܦܥ௥ሽǡݎ ൌ ͳǡڮ ǡ ܴ 
ۺ۱ ൌ ൛ ௛ܲǡ௛ାଵൟǡ ݄ ൌ ͳǡڮ ǡܪ  
   
(4) 
In each scaffold layerۺܐ, the set ܁ۺ consists of geometric 
information of scaffold. Set܁ۺ consists of biological features 
ሼܤܨ௟ሽǡ ݈ ൌ 1ǡڮ ǡ ܮ and biological material distribution regions 
given byሼܴ௥ሽǡ ݎ ൌ ͳǡڮ ǡ ܴ. These regions represent the tissue 
regeneration areas over which growth factor release rates have 
to be controlled during natural tissue morphogenesis or tissue 
repair. In each layer, this tissue repair occurs from different 
biological features ܤܨ௟  and follows through the regions ܴ௥ . 
The tissue growth constraintܩܥ௟ǡ௥ǡ ݈ ൌ ͳǡڮ ǡ ܮǢ ݎ ൌ ͳǡڮ ǡ ܴ 
in set ۵۱ represents topological positions of each region ܴ௥ 
with respect to biological feature ܤܨ௟ . In each layer, the 
different biological particle change boundaries ܴ݁ሺݑሻ between 
each region ܴ௥  are modeled as ݌௧௛  degree NURBS curve 
given by: 
ܴ݁ሺݑሻ ൌ
σ ௜ܰǡ௣ሺݑሻ௜௜ூ௜ୀ଴
σ ௜ܰǡ௣ሺݑሻ௜ூ௜ୀ଴
 (5) 
where,    Q௜ ൌ ൫x௜ ǡ y௜ ǡ z௜൯ are control points of curve obtained 
by curve fitting with weights w௜  and ௜ܰǡ௣ሺݑሻ are the B-spline 
basis functions defined on the knot vectors, ܷ.  
Further, within each region ܴ௥ the composition of 
biological material ܤܯ௞ is given by ܤܯ௞
ோೝǡ ݇ ൌ
Ͳǡڮ ǡ ܭǢ ݎ ൌ ͳǡڮ ǡ ܴ . In this way, the biological material 
distribution in each layer is represented by region wise 
biological material composition ܀۰ۻ . The biological 
materials compositions ܤܯ௞
ோೝ  are constrained using set of 
distribution constraints۲۱ in each region ܴ௥  inside scaffold 
geometry. The distribution constraint maintains the distribution 
requirements of biological material compositionܤܯ௞
ோೝ  in each 
region ܴ௥  such that each biological material ܤܯ௞  is properly 
distributed as per distribution function. Further, each scaffold 
layerۺܐ is separated from adjacent layersۺܐା૚to maintain a 
given porosity level ۺ۱  given by  ௛ܲǡ௛ାଵǡ ݄ ൌ ͳǡڮ ǡܪ . This 
layer level representation is explained in Fig. 3.  
 
 
Fig. 4. One-dimensional bioactive particle distribution between different 
biological features. 
In order to model the heterogeneous scaffold with biological 
materials and desired porosity level, each scaffold layer is 
designed with several biodegradable material or hydrogel 
filaments with bioactive particles. The collection of ܧ 
filaments ۴ۺ܍  in each layer is given by ۴ۺ ൌ ሼ۴ۺ܍ሽǡ ݁ ൌ
ͳǡڮ ǡ ܧ . The set ۴ۺ܍  consists of structural and material 
information of base scaffold material and bioactive particles in 
scaffold and constraint of volume fraction between them. Each 
filament ۴ۺ܍ is modeled as follows: 
 
۴ۺ܍ ൌ ሺ۰ۻ۵ǡ܀۰ۻǡ ܄۱ǡ ۾۱ǡ ۽ሻ 
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۰ۻ۵ ൌ ሼܨ௔ሺ݈݁݊݃ݐ݄ǡ ݀݅ܽ݉݁ݐ݁ݎሻǡ ܤܵ௕ሺ݀݅ܽ݉݁ݐ݁ݎǡ ݎ݈ܽ݀݅ܽ݀݅ݏݐܽ݊ܿ݁ǡ ݋ݎ݅݁݊ݐܽݐ݅݋݊ሻሽǡ 
ܽ ൌ ͳǡڮ ǡ ܣǢ ܾ ൌ ͳǡڮ ǡ ܤ 
܀۰ۻ ൌ ൛ܤܯ௞
ோೝൟǡ݇ ൌ ͳǡڮ ǡ ܭǢ ݎ ൌ ͳǡڮ ǡ ܴ 
܄۱ ൌ ൛ܸܥ௥ǣ σ ܤܯ௞
ோೝ ൌ ͳ௄௞ୀ଴ ൟǡݎ ൌ ͳǡڮ ǡ ܴ                       (6) 
۾۱ ൌ ൛ ௔ܲǡ௔ାଵൟǡ ܽ ൌ ͳǡڮ ǡ ܧ െ ͳ 
۽ ൌ ൛߬௛ǡ௛ାଵι ൟǡ݄ ൌ ͳǡڮ ǡܪ 
The geometric information of biological materials 
(biodegradable scaffold material and bioactive particles) in 
each filament ۴ۺ܍  is stored in set ۰ۻ۵ . Considering that 
biological materials have regular geometric shapes, the 
biodegradable scaffold material ܤܯ଴ is modeled as a 
filamentܨ௔ሺ݈݁݊݃ݐ݄ǡ ݀݅ܽ݉݁ݐ݁ݎ) with cylindrical shape having 
(length, diameter) as two parameters to represent its shape. 
Similarly, the bioactive micro-particles with growth factors or 
proteins ܤܯ௞ǡ ݇ ൌ ͳǡڮ ǡ ܭ represented as 
ܤܵ௕ሺ݀݅ܽ݉݁ݐ݁ݎǡ ݎ݈ܽ݀݅ܽ݀݅ݏݐܽ݊ܿ݁ǡ ݋ݎ݅݁݊ݐܽݐ݅݋݊ሻ  and are 
assumed to be of spherical shape with parameters as (diameter, 
radial distance, and orientation) within each filament۴ۺ܍. The 
region wise biological material composition set܀۰ۻ is used 
to represent the composition of biological material ܤܯ௞ within 
each regionܴ௥the filament ۴ۺ܍ passes through. Within each 
region ܴ௥  of filament ۴ۺ܍  the composition of biological 
material ܤܯ௞is given by ܤܯ௞
ோೝǡ ݇ ൌ Ͳǡڮ ǡ ܭǢ ݎ ൌ ͳǡڮ ǡ ܴ . 
In order to maintain the heterogeneity in each region ܴ௥of the 
scaffold layer, the biological materials ܤܯ௞must satisfy the 
volume constraints given by ܸܥ௥  in set ܄۱  such 
that σ ܤܯ௞
ோೝ ൌ ͳǡ ݎ ൌ ͳǡڮ ǡ ܴ௄௞ୀ଴ . Also, to maintain the 
porosity in each layer, we represent the porosity level ۾۱ ൌ
൛ ௔ܲǡ௔ାଵൟǡ ܽ ൌ ͳǡڮ ǡ ܧ െ ͳ between any two adjacent filaments 
۴ۺ܉ and۴ۺ܉ା૚. Further, the filaments in a particular layer at 
height ݄  are oriented with filaments of layer at height ݄ ൅
ͳby߬௛ǡ௛ାଵι . This set of orientation ۽ ൌ ൛߬௛ǡ௛ାଵι ൟǡ ݄ ൌ ͳǡڮ ǡܪ 
will also decide the porosity level between any two adjacent 
layers. 
Fig. 5 shows an example of internal architecture of a layer. 
The filament ۴ۺ૚  and ۴ۺ૛  are separated to maintain porosity 
level  ଵܲǡଶ . Between the biological features ܤܨଵ  and ܤܨଶ , 
biological material is distributed in regions given 
by ܴଵǡ ܴଶǡ ܴଷ . In this example, the biodegradable scaffold 
material ܤܯ଴ is modeled as a filament of cylindrical shape and 
the bioactive particles (growth factors or proteins) ܤܯଵǡ ܤܯଶ 
are modeled as spherical shapes. 
 
 
Fig. 5. Internal architecture of a layer made with biodegradable material 
(filaments), growth factors (spheres), and porosity level. 
3. Biomimetic design of scaffolds with bioactive particles 
In previous section, feature based heterogeneous scaffold 
model hierarchy was presented and bioactive particle 
distribution between different biological features was 
illustrated. In this section, the methodology for biomimetic 
design of scaffolds with bioactive particles by obtaining three 
dimensional CAD model of tissue construct and the biological 
features is discussed. 
3.1. Biological feature recognition 
In order to facilitate the design of heterogeneous scaffold 
consisting of varying bioactive particle distribution, biological 
entities are used as biological features. By selecting proper 
biological entities as the reference features and specifying a 
particle distribution function across the features, distribution 
information can be incorporated with biological feature 
information. The process to obtain biological features from the 
tissue region is discussed below. 
Our aim is to reconstruct the three-dimensional structure of 
the tissue regeneration volume from image data. Fig. 6, shows 
the steps involved in construction of 3D CAD model of tissue 
construct to be fabricated. Noninvasive imaging techniques 
could be used for biological feature recognition. Thin-slice 
computer tomography (CT) imaging, micro CT imaging, 
contrast-enhanced MRI, micro MRI and digital photography 
are some of the techniques that offer a noninvasive quantitative 
assay for the wound imaging[14]. The image acquisition 
system must preserve as much information of tissue 
regeneration area as possible. 
 
 
 
Fig. 6. Overview of entire image reconstruction 
3.2. Scaffold matrix modeling 
After the 3D reconstruction of the image is obtained, the 
outer surface boundaries of the 3D CAD model are used as 
scaffold boundaries represented with set of scaffold boundaries 
ሼܵܤ௠ሽǡ ݉ ൌ 1ǡ ڮ ǡܯ  and ܵܤ௠ሺݑǡ ݒሻ  are represented as 
NURBS surfaces using Equations (2). This surface model 
ܵܤଵሺݑǡ ݒሻ  is sliced into layers to decompose it into planar 
curves or scaffold boundary ܥܾሺݑሻ . This information from 
sliced layered plane is used in an ordered sequence during 
fabrication process. The slicing thickness parameter ݖ௛ is used 
to decompose the 3D volume. The set ۺ  is introduced to 
indicate the discrete layers into which surface model is 
decomposed. 
 
ۺ ൌ ሼۺܐǣ ۺ૚ ൏ ۺ૛ ൏ ڮۺ۶ି૚ ൏ ۺ۶ሽǡ ݄ ൌ ͳǡڮ ǡܪ (7) 
 
where ۺܐ represents the ݄௧௛ decomposed layer. 
 
After slicing, in each layer ۺܐ , the scaffold boundary 
ܥܾ௅೓ሺݑሻ is modeled as ݌௧௛ degree NURBS curve given by: 
ܥܾ௅೓ሺݑሻ ൌ
σ ௜ܰǡ௣ሺݑሻ௜௜ூ௜ୀ଴
σ ௜ܰǡ௣ሺݑሻ௜ூ௜ୀ଴
     (8) 
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where, C௜ ൌ ൫x௜ ǡ y௜ ǡ z௜൯ are control points of curve obtained 
by curve fitting with weights w௜  and ௜ܰǡ௣ሺݑሻ are the B-spline 
basis functions defined on the knot vectors ܷ.  
By decomposing the surface model, each layer can be 
modeled and fabricated using solid free form fabrication 
method, as seen in Fig. 7. A 3D reconstruction of image along 
with biological features ܤܨଵand ܤܨଶ  is shown in Fig. 7(a). 
This 3D CAD model consists of scaffold boundaries ܵܤଵሺݑǡ ݒሻ 
andܵܤଶሺݑǡ ݒሻ. To model the 3D porous scaffold structure, the 
outer surface ܵܤଵሺݑǡ ݒሻ  is sliced at different heights ݖ௛  and 
decomposed in layer ۺܐ  as shown in Fig. 9(b).  Further, a 
scaffold boundaryܥܾ௅೓ሺݑሻ as seen in Fig. 7(c) is obtained after 
slicing a surface with parallel planes. Fig. 7(d) shows modeled 
porous layers with biodegradable material filaments using 
scaffold boundaries ܥܾ௅೓ሺݑሻ . After stacking such several 
layers along a build direction, 3D scaffold structure is obtained 
as seen in Fig. 7(e). The build direction is chosen such that the 
scaffold structure can withstand the weight of top layers by its 
own without any need of extra support material. Note that the 
scaffold model consists of simply the biodegradable material 
matrix and there are no bioactive particles in it.  
 
 
Fig. 7. Scaffold model without any bioactive particles 
3.2 Spatial bioactive particle variation 
 
In the previous sections, biological features, 3D reconstructed 
geometry and scaffold structures are obtained from the tissue 
reconstruction volume. For biomimetic designs, scaffolds 
mimic natural tissue structure and seek to replicate all aspects 
of tissue structure and function. Since tissue formation and 
repair is a complex cascade of events in which a number of 
growth factors are involved, controlled delivery of 
combinations of growth factors from micro-particles embeded 
in scaffold appear to be a logical strategy in mimicking nature. 
For bone regeneration, wound healing or blood vessel 
formation, the tissue formation ideally takes place from healthy 
tissue area to damaged tissue area. This morphological change 
from one tissue region to other tissue region can be seen as 
steps of tissue growth and it requires appropriate growth factors 
to be released from scaffolds in spatial and temporal fashion. 
By imitating this tissue regeneration sequence, the growth 
factor, protein variation across biological features of tissues can 
be estimated by means of volume lofting method. This section 
discusses the methodology of obtaining spatial bioactive 
particle variation across biological features in order to imitate 
the natural tissue regeneration process.  
For using volume lofting method, it is assumed that all the 
biological features ܤܨଵǡ ܤܨଶ are represented as entities such as 
point or NURBS curves/surfaces. Given any two biological 
features as geometric surface entities, using volume lofting 
method, the biological material information is lofted between 
the features ܤܨଵ andܤܨଶ. The lofting of NURBS surface along 
an arbitrary trajectory curve ܶݎሺ݃ሻ  is discussed below. The 
trajectory of lofting in ݃ direction is denoted by a straight line, 
given by: 
 
ܶݎሺ݃ሻ ൌ σ ேೞǡ೟ሺ௚ሻ
ೄ
ೞసబ ௪ೞ܂ೞ
σ ேೞǡ೟ሺ௚ሻೄೞసబ ௪ೞ
   (9) 
where, T௦ ൌ ൫x௦ǡ y௦ǡ z௦൯  and  w௦  are weights of each T௦ . 
௦ܰǡ௧ሺ݃ሻare the B-spline basis functions defined on the knot 
vectors, ܩ, with degree ݐ.  
The outer tissue boundary or biological boundary ܤܨଵ  is 
modeled as NURBS surface as given by Equation 2: 
 
ܵܤଵሺݑǡ ݒሻ ൌ
σ σ ௜ܰǡ௣ሺݑሻ ௝ܰǡ௤ሺݒሻ௜ǡ௝ ௜ǡ௝௃௝ୀ଴ூ௜ୀ଴
σ σ ௜ܰǡ௣ሺݑሻ ௝ܰǡ௤ሺݒሻ௜ǡ௝ ௃௝ୀ଴ூ௜ୀ଴
 (10) 
 
where, P௜ǡ௝ ൌ ቀx௜ǡ௝ǡ y௜ǡ௝ǡ z௜ǡ௝ቁ  and  w௜ǡ௝  are weights of each P௜ǡ௝. ௜ܰǡ௣ሺݑሻ, ௝ܰǡ௤ሺݒሻ are the B-spline basis functions defined 
on the knot vectors, ܷ andܸ, with degree ݌ and ݍ respectively.  
The lofted volume ܮݒሺݑǡ ݒǡ ݃ሻ  is obtained by lofting 
biological boundary ܵܤ௠ሺݑǡ ݒሻ along the straight lineܶݎሺ݃ሻ. 
Thus, lofted volume ܮݒሺݑǡ ݒǡ ݃ሻ  of degree ሺ݌ǡ ݍǡ ݐሻ  with 
parameters ݑǡ ݒǡ ݃ and knot sequence U, V, G is given as: 
 
ܮݒሺݑǡ ݒǡ ݃ሻ ൌ σ σ σ ே೔ǡ೛
ሺ௨ሻேೕǡ೜ሺ௩ሻೄೞసబ ேೞǡ೟ሺ௚ሻ௪೔ǡೕǡೞ೔ǡೕǡೞ಻ೕసబ಺೔సబ
σ σ σ ே೔ǡ೛ሺ௨ሻேೕǡ೜ሺ௩ሻೄೞసబ ேೞǡ೟ሺ௚ሻ௪೔ǡೕǡೞ
಻
ೕసబ
಺
೔సబ
  (11) 
The regions between lofted volumes represent 
morphological change from one tissue region to other tissue 
region and hence the continuous bioactive particles (with 
growth factors or proteins) composition change between 
different biological features. Creating a large number of lofted 
volume regions at parametric distance ݃ will give a smooth 
variation of bioactive particles changing between the biological 
features. This lofted volume information will be used for 
mapping the 3D bioactive particle composition variation into 
2D plane for modeling and fabrication purpose.  
An example of 3-D wound closure direction and the lofted 
volume is shown in Fig8 . In case of open wound healing, 
contraction phenomenon is observed. Contraction is the 
process in which the surrounding skin is pulled 
circumferentially toward the wound [15]. After generating the 
3D surface data of wound, the outer surface ܵܤଵሺݑǡ ݒሻ  is 
assigned as a biological feature ܤܨଵand then the innermost 
region projected on top surface as second biological 
featureܤܨଶ. The wound closure is assumed to follow the path 
from outer surface to top surface and the morphological change 
from biological featureܤܨଵtoܤܨଶis obtained using volume 
lofting operation discussed using Equations 9 to 11. The 
surface ܵܤଵሺݑǡ ݒሻ is lofted along ܶݎሺ݃ሻ direction to obtain 3D 
lofted volume (Fig 8(a)). Each of the regions in lofted volume 
are separated by parametric distance ݃  from biological 
featureܤܨଵ. For illustration purpose, between the features ܤܨଵ 
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andܤܨଶ, the lofted volume regions with varying growth factor 
composition are shown asܴଵǡ ܴଶǡ ܴଷǡ ܴସǡ ܴହ.  
Figure 8(b) shows a one-dimensional variation  ௞݂ሺ݃ሻ of 
bioactive particle ܤܯ௞parameterized between the biological 
featuresܤܨଵ andܤܨଶ. The bioactive particle requirements for 
each lofted volume regions can be obtained by using the 
parametric distance ݃ from biological featureܤܨଵ. 
The lofted volume is decomposed into discrete layers using 
slicing. The slicing thickness parameter ݖ௛  is used to 
decompose the 3D volume. A set ۺ given by Equation 7 is 
introduced to indicate the discrete layers into which surface 
model is decomposed. In each layer, the different bioactive 
particles change boundariesܴ݁ሺݑሻ between each region ܴ௥ are 
modeled as ݌௧௛ degree NURBS curve given by Equation 5.  
 
Fig. 8. Wound closure in 2D plane 
Figure 8(a) shows the lofted volume sliced at different 
heights. In slice 1, five different regions can be seen, each 
region having distribution of bioactive particles, obtained by 
slicing the lofted volume as shown in Fig 8(c). Similarly, in 
slice 2 (Fig 8(d)), two different regions are shown are slicing 
lofted volume. 
Considering Fig. 8(c), five different 
regionsܴଵǡ ܴଶǡ ܴଷǡ ܴସǡ ܴହ represents the regions over which 
tissue repair progresses from biological feature ܤܨଶ  to ܤܨଵ . 
Fig. 8(b) shows the distribution of growth factor ܤܯ௞  that is 
required between the biological features ܤܨଵ  and ܤܨଶ  and is 
given by function  ௞݂ሺ݃ሻ . Using the parametric distances of 
boundaries of regions ܴଵǡ ܴଶǡ ܴଷǡ ܴସǡ ܴହ from biological 
feature ܤܨ௞ , the composition of growth factor ܤܯ௞  in each 
region is obtained asܤܯ௞
ோభǡ ܤܯ௞
ோమǡ ܤܯ௞
ோయǡ ܤܯ௞
ோరǡ ܤܯ௞
ோఱ  from 
the distribution function. Finally, the bioactive particles have 
to be distributed between in each of regionsܴଵǡ ܴଶǡ ܴଷǡ ܴସǡ ܴହ 
so as to follow the distribution function  ௞݂ሺ݃ሻ. In this way, 
using lofted volume and distribution functions  ௞݂ሺ݃ሻǡ ݇ ൌ
ͳǡڮ ǡ ܭ constrained between the two biological features, ܤܨଵ 
andܤܨଶ , the composition arrayܤܯ௞
ோೝis generated using the 
parametric distance ݃ from biological features. 
For more than one type of bioactive particlesܤܯ௞ , more 
than one distribution functions  ௞݂ሺ݃ሻǡ ݇ ൌ ͳǡڮ ǡ ܭ  will be 
needed, where the distribution varies only in one parametric 
direction݃. Also, based on design requirements, distribution in 
more than one parametric direction can also be implemented. 
The micro-particles with growth factor composition in the 
scaffold case may be first-order continuous or higher[16]. More 
information and examples about the lofted volume can be 
found in [4, 17]. 
4. Implementation and 3D printing of heterogeneous 
scaffolds for skin tissue engineering 
The scaffold design begins with the acquisition of non-
invasive images and image processing of appropriate tissue 
region of interest. Sliced images of the targeted tissue can be 
obtained by using CT methods. Once the sliced images are 
obtained, they are imported into ITK-SNAP [18]. ITK-SNAP 
implements the 3D geodesic active contour method as well as 
the region competition method for image segmentation. This is 
followed by a 3D reconstruction of anatomical structure using 
available software kits like Mimics or ITK-SNAP. For external 
skin wounds, digital cameras can be used to get high quality 
images of the region. For the external skin images, image 
processing was performed on the sample image using 
MATLAB Image Processing Toolbox.  
Once the 3D surface model of tissue was generated, it was 
imported into Rhinoceros 5.0 software for surface refinement 
and non-uniform rational B-spline (NURBS) surface 
generation. Using the 3D surface model, biological features are 
obtained and iso-surfaces are created by volume lofting 
operation between biological features. Further, thin slices were 
created and sliced data were obtained in the form of lofted 
NURBS curves. In this way the iso-composition contours in 
each slice were obtained and used for distribution of bioactive 
particles over the scaffold. 
To physically implement the proposed algorithm, we made 
two major assumptions for the sake of simplicity. First, 
fluorescent microbeads were incorporated inside a hydrogel 
matrix instead of real active particles with proteins (Fig. 9 (a)) 
such a way that low, average, and high concentrations of 
growth factor volume fractions were represented by red, blue, 
and transparent colors, respectively. Moreover, we confined 
the number of regions with uniform functionality to three (Fig. 
9 (b)). We used our recently published method [12] of 3D 
printing for the implementation of algorithm in the previous 
section. This method is based on an aspiration on demand 
protocol for assembling of multi-material segments in low 
viscous state followed by in situ gel formation. Agarose was 
used as the carrier hydrogel for fluorescent microbeads to be 
able to make different regions of the 3D printed scaffold 
visually distinguishable. To prepare the starting materials, 2 
wt.% agarose hydrogels were prepared according to the 
producer’s protocol (Sigma, USA) by boiling water bath 
method. Fluorescent microbeads (Createx Colors, USA) were 
added to the hydrogels during the preparation to stain each 
hydrogel region. The multi-region structure was fabricated by 
the in house developed 3D printer (SU3D) which is shown in 
Fig 9(c). The 3D printed scaffold with three regions is shown 
in Fig. 9(d).  
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Fig. 9: An example of implemented algorithm for 3D printing of an object 
with three regions of heterogeneity (scale bar in the printed construct is 4mm) 
The advantages of using this method are the high 
dimensional precision of switching between neighboring 
regions; ease of material switching due to high accessibility of 
different inks during the process; and producing constructs 
with high structural integrity because of using single nozzle 
design. More details about the process parameters and its 
features is available at [12]. 
 
5. Conclusions 
In this paper, feature based modeling of heterogeneous 
scaffolds is presented for biomimicking the healing process. 
Using image segmentation methods, 3D model of tissue 
regeneration volume is obtained. Biological features that 
control growth factor distribution are identified as features 
because they dictate the bioactive particle (growth factors or 
proteins) variation inside a heterogeneous object. These 
bioactive particles are distributed between biological features 
using volume lofting method. Based on design requirements, 
the lofted volume is sliced and each sliced layer is modeled with 
bioactive particles distributed as per given distribution function. 
Computational algorithms are developed to vary bioactive 
particles continuously across the biological features of scaffold. 
This approach led to achieve a tailored distribution of bioactive 
micro-particles with growth factors and biological particles 
based on the demanded release profiles and the biological 
properties of the modeled tissue constructs. A 3D printed 
scaffold with three regions is provided as an example for 
physical implementation of developed algorithm to validate the 
concept. 
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